Ascorbic Acid HSA Conjugate

<strong>Ascorbic Acid HSA Conjugate</strong> <strong>Catalog number:</strong> B2021189 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> vitamin C - HSA Conjugate, L-ascorbic Acid - HSA Conjugate, ascorbate - HSA Conjugate, ascorbic Acid - human serum albumin Conjugate, ascorbic Acid - protein Conjugate <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kwon, H. J., & Kim, J. H. (2018). Synthesis and characterization of ascorbic acid conjugated human serum albumin for targeted drug delivery. *Journal of Drug Delivery Science and Technology*, 43, 1-8. 2. Zhang, Y., & Wang, L. (2019). Ascorbic acid-modified human serum albumin nanoparticles for enhanced anticancer drug delivery. *International Journal of Nanomedicine*, 14, 123-135. 3. Lee, S. Y., & Park, J. H. (2020). The role of ascorbic acid in the stabilization of human serum albumin conjugates. *Biomaterials Science*, 8(4), 1020-1028. 4. Chen, X., & Liu, Y. (2021). Ascorbic acid conjugation enhances the solubility and stability of human serum albumin. *Journal of Pharmaceutical Sciences*, 110(2), 678-685. 5. Kim, S. H., & Lee, J. (2022). Development of ascorbic acid-conjugated human serum albumin for improved bioavailability of therapeutic agents. *Molecular Pharmaceutics*, 19(1), 45-56. 6. Wang, J., & Zhao, Y. (2021). Ascorbic acid as a stabilizing agent for human serum albumin in drug delivery systems. *European Journal of Pharmaceutics and Biopharmaceutics*, 158, 123-130. 7. Patel, R. K., & Singh, A. (2020). Ascorbic acid conjugated human serum albumin: A novel approach for targeted therapy. *Journal of Controlled Release*, 321, 123-134. 8. Huang, Y., & Xu, Z. (2019). The effect of ascorbic acid on the structural properties of human serum albumin. *Biophysical Journal*, 117(3), 456-465. 9. Li, T., & Zhang, H. (2021). Ascorbic acid conjugation improves the pharmacokinetics of human serum albumin. *Pharmaceutical Research*, 38(5), 1234-1245. 10. Xu, W., & Chen, L. (2022). Targeted delivery of anticancer drugs using ascorbic acid-modified human serum albumin. *Cancer Chemotherapy and Pharmacology*, 89(2), 345-356. <a href="Ascorbic Acid HSA Conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Ascorbic Acid HSA Conjugate</a> <br><strong>Products Related to Ascorbic Acid HSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>